Clinical trials sponsored by China Immunotech (Beijing) Biotechnology Co., Ltd.

Phase breakdown

Conditions studied

Recruiting trials led by China Immunotech (Beijing) Biotechnology Co., Ltd.

• A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
  NCT07104721 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
  NCT06978647 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus
  NCT06943937 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases
  NCT07123519 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease
  NCT06379646 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
  NCT07236762 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases
  NCT07236801 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations

Common questions

How many trials is China Immunotech (Beijing) Biotechnology Co., Ltd. recruiting for?

China Immunotech (Beijing) Biotechnology Co., Ltd. is the lead sponsor of 7 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.